Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 103370

In scope icon M 7 E
QID 103370 (Type "103370" in App Search)
A 32-year-old G1P0 woman at 33 weeks gestation is brought to labor and delivery by her husband after a witnessed seizure at her home. She states that she has had worsening headaches over the past several days not responsive to over the counter medications at home. Her temperature is 98.6°F (37.0°C), pulse is 95, blood pressure is 165/90 mmHg, respirations are 18/min and oxygen saturation is 99% on room air. On exam, she is alert and answers questions appropriately, though does appear fatigued. 2+ edema is noted at the ankles. Urinalysis is obtained and demonstrates 3+ protein. Which of the following is the most appropriate pharmacotherapy for seizure prophylaxis in this patient?

Carbemazepine

88%

14/16

Lamotrigine

12%

2/16

Lorazepam

0%

0/16

Magnesium sulfate

0%

0/16

Phenobarbitol

0%

0/16

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient with persistent headaches, seizure activity, and hypertension has eclampsia. Patients with eclampsia or pre-eclampsia should be treated with magnesium sulfate to reduce the risk of seizures.

Tonic-clonic seizures, also called eclamptic convulsions, are the hallmark of eclampsia. Such seizures typically occur once signs of pre-eclampsia, including hypertension and proteinuria, are already present. While not fully understood, pre-eclampsia and eclampsia are thought to develop due to abnormalities in the development of placental vasculature, along with the release of placental and maternal factors. By definition, pre-eclampsia is defined as the onset of hypertension and proteinuria or end organ dysfunction after 20 weeks of gestation. Pre-eclampsia and eclampsia may also occur up to several weeks after delivery. Magnesium sulfate is the treatment of choice for seizure prophylaxis in patients with eclampsia. Eclampsia is managed definitively with delivery of the baby and placenta.

Leeman et al. report that preeclampsia is the development of new-onset hypertension with proteinuria after 20 weeks of gestation. The adverse pregnancy outcomes related to severe preeclampsia are caused primarily by the need for preterm delivery. Magnesium sulfate is the drug of choice to prevent and treat eclampsia.

Fogleman writes that magnesium sulfate is the treatment of choice for seizure prophylaxis in patients with pre-eclampsia and eclampsia because the medication prevents seizures without adverse affects to the soon to be born fetus at 18 months of age. The author notes that magnesium increases the risk of Cesarian section and side effects such as flushing as well as cardiac and respiratory depression.

Illustration A shows a treatment algorithm for patients with severe pre-eclampsia as recommended by Leeman et al.

Incorrect answers:
Answer 1: Carbemazepine is an anti-epileptic drug used in the management of some seizure disorders and trigeminal neuralgia. However, it is associated with risk of fetal cardiac malformaiton and neural tube defects. It is not indicated in the management of eclampsia.

Answer 2: Lamotrigine is an anti-epileptic drug used in the management of some seizure disorders. However, it is associated with particularly high risk of fetal neural tube defects. It is not indicated in the management of eclampsia.

Answer 3: Lorazepam is a benzodiazepine medication that is used to abort seizure activity. It is indicated in some patients with eclampsia who are actively seizing and have not responded to magnesium sulfate. However, it is not the most appropriate initial medication for this patient.

Answer 5: Phenobarbitol is a barbiturate medication that is used in the treatment of alcohol withdrawal and seizures. It is more commonly used for treatment of seizures in neonates. It is not indicated in the management of eclampsia.

Bullet Summary:
Patients with eclampsia or pre-eclampsia should be treated with magnesium sulfate to reduce the risk of seizures.

ILLUSTRATIONS:
REFERENCES (2)
Authors
Rating
Please Rate Question Quality

5.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(3)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options